Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study - Concepedia

Concepedia

Publication | Open Access

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

DOI Full Paper Access

47

Citations

21

References

2015

Year

Atsushi Ogata, Koichi Amano, Hiroaki Dobashi, Masayuki Inoo, Tomonori Ishii, Tsuyoshi Kasama, Shinichi Kawai, Atsushi Kawakami, Tatsuya Koike, Hisaaki Miyahara,

The Journal of Rheumatology

Abstract

TCZ-SC monotherapy maintained a favorable safety profile and consistent efficacy throughout the 108-week study. Like TCZ-IV, TCZ-SC could provide an additional treatment option for patients with RA.

References

	Year	Citations

Page 1